Developing therapies for triple-negative breast cancer subtypes. Okines A, Turner N. Lancet Oncol 2024 Jan 8:S1470-2045(23)00639.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Okines A, Turner N. Developing therapies for triple-negative breast cancer subtypes. Lancet Oncol 2024 Jan 8:S1470-2045(23)00639.
PMID: 38211607